Dow Up 0.07% Nasdaq Up 0.61%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
3.00 Up 0.20(7.14%) Nov 26, 4:00PM EST
|After Hours : 3.03 Up 0.03 (1.00%) Nov 26, 7:41PM EST
Prev Close:2.80
Open:2.85
Bid:N/A
Ask:3.14 x 5000
1y Target Est:7.00
Beta:3.29
Next Earnings Date:N/A
Day's Range:2.85 - 3.15
52wk Range:1.94 - 6.87
Volume:3,902,185
Avg Vol (3m):742,637
Market Cap:257.43M
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IDRA

Comparison

Symbol% ChgMkt Cap
IDRAUp 7.14%257.43M
DVAXUp 5.01%397.02M
PFEUp 2.07%195.95B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,203.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Dec-14) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback